Following the initiation of oral ferrous sulfate for newly diagnosed iron deficiency anemia, a structured follow-up plan is necessary to ensure therapeutic efficacy and replenish physiologic reserves. Arrange the following laboratory assessments and clinical actions in the appropriate chronological sequence for monitoring this patient's treatment response over time.
- 1Assess the reticulocyte count to confirm early bone marrow response
- 2Measure hemoglobin concentration to document correction of the anemia
- 3Evaluate serum ferritin levels to confirm the replenishment of total body iron stores
- 4Discontinue oral iron supplementation and transition to routine long-term surveillance
Cevap
The correct chronological sequence is to first assess the reticulocyte count, followed by measuring hemoglobin concentration, then evaluating serum ferritin levels, and finally discontinuing the oral iron supplementation.
The physiological response to iron supplementation dictates this monitoring sequence. The bone marrow's immediate response is to increase reticulocyte production (7-10 days). As these young red blood cells mature, the overall hemoglobin concentration rises, correcting the systemic anemia (1-2 months). Only after the anemia is fully corrected does the body begin to effectively store excess iron, reflected by a steady rise in serum ferritin (3-6 months). Therapy is discontinued only after these stores are fully replenished to prevent early relapse.
Adım Adım Çözüm
Anahtar Kavram
Monitoring response to oral iron therapy for iron deficiency anemia follows a predictable physiological timeline: reticulocytosis peaks first (1-2 weeks), followed by hemoglobin correction (6-8 weeks), and finally ferritin repletion (3-6 months).